Literature DB >> 14630300

Neurocognitive function and outcome in first-episode schizophrenia: a 10-year follow-up of an epidemiological cohort.

John Stirling1, Colin White, Shon Lewis, Richard Hopkins, Digby Tantam, Alice Huddy, Linda Montague.   

Abstract

The natural history of neurocognitive impairments in schizophrenia is unclear. We aimed to characterise this in an epidemiological first-episode cohort and relate it to long-term outcome. All but 1 of 112 first-episode psychosis cases ascertained from a geographical catchment area were traced at 10-12 years. Neurocognitive and multi-dimensional outcome assessments were made at interview in 49 cases with schizophrenia and related disorders. Twenty-four of these had completed the same neurocognitive battery at index admission. Comparisons with normative data showed impaired executive function in a proportion of the first episode (FE) sample at baseline. Significant deterioration was seen over the follow-up period in three of nine sub-tests: object assembly, picture completion and memory for designs. Neurocognitive impairments at outcome, but not baseline, correlated with clinical outcome. Poor outcome was associated with a decline in performance on visuo-spatial tasks and a failure to improve on frontal-temporal tasks during the follow-up period. Executive deficits may be present in the FE, but do not progress over 10-12 years. Visuo-spatial function is spared in the FE but may deteriorate over time. Changes in both these patterned deficits are predictive of clinical outcome.

Entities:  

Mesh:

Year:  2003        PMID: 14630300     DOI: 10.1016/s0920-9964(03)00014-8

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  43 in total

1.  Computer-assisted cognitive remediation in schizophrenia: what is the active ingredient?

Authors:  Matthew M Kurtz; James C Seltzer; Dana S Shagan; Warren R Thime; Bruce E Wexler
Journal:  Schizophr Res       Date:  2006-10-27       Impact factor: 4.939

2.  Factors associated with occupational and academic status in patients with first-episode psychosis with a particular focus on neurocognition.

Authors:  Marte Tandberg; Torill Ueland; Ole A Andreassen; Kjetil Sundet; Ingrid Melle
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-02-07       Impact factor: 4.328

Review 3.  Schizopsychotic symptom-profiles and biomarkers: beacons in diagnostic labyrinths.

Authors:  Tomas Palomo; Richard M Kostrzewa; Richard J Beninger; Trevor Archer
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

4.  Functional outcomes in community-based adults with borderline personality disorder.

Authors:  Kristin N Javaras; Mary C Zanarini; James I Hudson; Shelly F Greenfield; John G Gunderson
Journal:  J Psychiatr Res       Date:  2017-01-24       Impact factor: 4.791

5.  Cognitive deficits in recent-onset and chronic schizophrenia.

Authors:  S R Sponheim; R E Jung; L J Seidman; R I Mesholam-Gately; D S Manoach; D S O'Leary; B C Ho; N C Andreasen; J Lauriello; S C Schulz
Journal:  J Psychiatr Res       Date:  2009-10-29       Impact factor: 4.791

6.  Neurocognitive decline in early-onset schizophrenia compared with ADHD and normal controls: evidence from a 13-year follow-up study.

Authors:  Merete Øie; Kjetil Sundet; Bjørn Rishovd Rund
Journal:  Schizophr Bull       Date:  2008-09-18       Impact factor: 9.306

7.  Nonsocial and social cognition in schizophrenia: current evidence and future directions.

Authors:  Michael F Green; William P Horan; Junghee Lee
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

8.  Lifetime cannabis use and cognition in patients with schizophrenia spectrum disorders and their unaffected siblings.

Authors:  Ana M Sánchez-Torres; Virginia Basterra; Araceli Rosa; Lourdes Fañanás; Amalia Zarzuela; Berta Ibáñez; Víctor Peralta; Manuel J Cuesta
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-04-12       Impact factor: 5.270

9.  Neuropsychological impairments predict the clinical course in schizophrenia.

Authors:  Wolfgang Wölwer; Jürgen Brinkmeyer; Mathias Riesbeck; Lena Freimüller; Ansgar Klimke; Michael Wagner; Hans-Jürgen Möller; Stefan Klingberg; Wolfgang Gaebel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-11       Impact factor: 5.270

10.  Is there a degenerative process going on in the brain of people with Schizophrenia?

Authors:  Bjørn Rishovd Rund
Journal:  Front Hum Neurosci       Date:  2009-10-26       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.